Skip to main content
Clinical Trials/NCT01611389
NCT01611389
Unknown
Not Applicable

Minimizing Right Ventricular Pacing in Dual-chamber Pacemaker Patients With Sinus Node Disease and First Degree Atrioventricular Block.

Military Institute od Medicine National Research Institute1 site in 1 country60 target enrollmentSeptember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sinus Node Disease.
Sponsor
Military Institute od Medicine National Research Institute
Enrollment
60
Locations
1
Primary Endpoint
Oxygen uptake (cardiopulmonary exercise testing).
Last Updated
13 years ago

Overview

Brief Summary

The aim of this study is to evaluate the effect of minimizing right ventricular pacing in dual-chamber pacemaker patients with sinus node disease (SND) and first degree atrioventricular block (AVIB)on exercise capacity, quality of life and other heart failure measures.

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
December 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Military Institute od Medicine National Research Institute

Eligibility Criteria

Inclusion Criteria

  • prolonged PQ interval \> 200 ms,
  • percentage of right ventricular pacing with standard AV delay \> 90.

Exclusion Criteria

  • second or third degree atrioventricular block,
  • permanent atrial fibrillation.

Outcomes

Primary Outcomes

Oxygen uptake (cardiopulmonary exercise testing).

Time Frame: 3 months

Secondary Outcomes

  • Left ventricular ejection fraction.(3 months)
  • Quality of life(3 months)
  • Arrhythmia(3 months)
  • Ventilatory anaerobic threshold (cardiopulmonary exercise testing)(3 months)
  • VE/VCO2 slope (cardiopulmonary exercise testing).(3 months)

Study Sites (1)

Loading locations...

Similar Trials